BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 22878457)

  • 1. Isolated central nervous system relapse presenting as myeloid sarcoma of acute myeloid leukemia after allogeneic peripheral blood stem cell transplantation.
    Cho SF; Liu TC; Chang CS
    Ann Hematol; 2013 Jan; 92(1):133-5. PubMed ID: 22878457
    [No Abstract]   [Full Text] [Related]  

  • 2. [Cutaneous chloromas as the presenting feature of acute myeloid leukemia in a child].
    Roche-Gamón E; Febrer-Bosch I; Verdeguer A; Alegre de Miquel V
    Actas Dermosifiliogr; 2007 May; 98(4):293-4. PubMed ID: 17506966
    [No Abstract]   [Full Text] [Related]  

  • 3. Intrathecal chemotherapy and meningeal relapses in myelomonocytic AML. A single institution experience.
    Romani C; Di Tucci AA; Dessalvi P; Pettinau M; Emanuele A
    Am J Hematol; 2010 Mar; 85(3):219. PubMed ID: 20063278
    [No Abstract]   [Full Text] [Related]  

  • 4. Less intense conditioning with fludarabine, cyclophosphamide, idarubicin and etoposide (FCIE) followed by allogeneic unselected peripheral blood stem cell transplantation in elderly patients with leukemia.
    Schlenk RF; Hartmann F; Hensel M; Jung W; Weber-Nordt R; Gabler A; Haas R; Ho AD; Trümper L; Döhner H
    Leukemia; 2002 Apr; 16(4):581-6. PubMed ID: 11960336
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Standard versus alternative myeloablative conditioning regimens in allogeneic hematopoietic stem cell transplantation for high-risk acute leukemia.
    Mengarelli A; Iori A; Guglielmi C; Romano A; Cerretti R; Torromeo C; Micozzi A; Fenu S; Laurenti L; Donato V; De Felice L; Arcese W
    Haematologica; 2002 Jan; 87(1):52-8. PubMed ID: 11801465
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Donor cell-derived acute myeloid leukemia developing 14 months after matched unrelated bone marrow transplantation for chronic myeloid leukemia.
    Hambach L; Eder M; Dammann E; Battmer K; Stucki A; Heil G; Ganser A; Hertenstein B
    Bone Marrow Transplant; 2001 Oct; 28(7):705-7. PubMed ID: 11704795
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Allogeneic hematopoietic cell transplantation in children with relapsed acute lymphoblastic leukemia isolated to the central nervous system.
    Harker-Murray PD; Thomas AJ; Wagner JE; Weisdorf D; Luo X; DeFor TE; Verneris MR; Dusenbery KE; MacMillan ML; Tolar J; Baker KS; Orchard PJ
    Biol Blood Marrow Transplant; 2008 Jun; 14(6):685-92. PubMed ID: 18489994
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Myeloid sarcoma presenting in muscle-tissue of the lower limb: unusual origin of a compartment-syndrome.
    Scheipl S; Leithner A; Radl R; Beham-Schmid C; Ranner G; Linkesch W; Windhager R
    Am J Clin Oncol; 2007 Dec; 30(6):658-9. PubMed ID: 18091063
    [No Abstract]   [Full Text] [Related]  

  • 9. Second allogeneic hematopoietic stem cell transplantation (HSCT) results in outcome similar to that of first HSCT for patients with juvenile myelomonocytic leukemia.
    Yoshimi A; Mohamed M; Bierings M; Urban C; Korthof E; Zecca M; Sykora KW; Duffner U; Trebo M; Matthes-Martin S; Sedlacek P; Klingebiel T; Lang P; Führer M; Claviez A; Wössmann W; Pession A; Arvidson J; O'Marcaigh AS; van den Heuvel-Eibrink MM; Starý J; Hasle H; Nöllke P; Locatelli F; Niemeyer CM
    Leukemia; 2007 Mar; 21(3):556-60. PubMed ID: 17268527
    [No Abstract]   [Full Text] [Related]  

  • 10. Voriconazole in the management of invasive aspergillosis in two patients with acute myeloid leukemia undergoing stem cell transplantation.
    Mattei D; Mordini N; Lo Nigro C; Ghirardo D; Ferrua MT; Osenda M; Gallamini A; Bacigalupo A; Viscoli C
    Bone Marrow Transplant; 2002 Dec; 30(12):967-70. PubMed ID: 12476292
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Allogeneic stem cell transplantation with fludarabine-based, less intensive conditioning regimens as adoptive immunotherapy in advanced Hodgkin's disease.
    Anderlini P; Giralt S; Andersson B; Ueno NT; Khouri I; Acholonu S; Cohen A; Körbling MJ; Manning J; Romaguera J; Sarris A; Rodriguez ; Hagemeister F; Mclaughlin P; Cabanillas F; Champlin RE
    Bone Marrow Transplant; 2000 Sep; 26(6):615-20. PubMed ID: 11041566
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Successful treatment with nonmyeloablative allogeneic hematopoietic stem cell transplantation in a patient with acute myeloid leukemia complicated with pulmonary infection.
    Choi I; Abe Y; Ohtsuka R; Matsushima T; Tachikawa Y; Nagasawa E; Nishimura J; Inaba S; Nawata H; Muta K
    Int J Hematol; 2004 Jan; 79(1):92-4. PubMed ID: 14979485
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Favorable outcome with STI571 (imatinib mesylate) and allogeneic stem cell transplantation in a case of Ph+ chemorefractory acute lymphocytic leukaemia.
    Wernstedt P; Brune M; Andersson PO; Gustavsson B; Stockelberg D; Wadenvik H
    Bone Marrow Transplant; 2002 Dec; 30(12):971-3. PubMed ID: 12476293
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Three cases of renal relapse after allogeneic hematopoietic stem cell transplantation for childhood acute lymphoblastic leukemia.
    Huck K; Laws HJ; Meisel R; Traeger A; Bernbeck B; Schonberger S; Stackelberg VA; Pape H; Dilloo D
    Haematologica; 2006 May; 91(5 Suppl):ECR07. PubMed ID: 16709515
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sequential intensified conditioning and tapering of prophylactic immunosuppressants for graft-versus-host disease in allogeneic hematopoietic stem cell transplantation for refractory leukemia.
    Liu QF; Fan ZP; Zhang Y; Jiang ZJ; Wang CY; Xu D; Sun J; Xiao Y; Tan H
    Biol Blood Marrow Transplant; 2009 Nov; 15(11):1376-85. PubMed ID: 19822296
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Central nervous system relapse after bone marrow transplantation for acute leukemia in first remission.
    Singhal S; Powles R; Treleaven J; Horton C; Tait D; Meller S; Pinkerton CR; Mehta J
    Bone Marrow Transplant; 1996 Apr; 17(4):637-41. PubMed ID: 8722368
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A new combination of carboplatin, high-dose cytarabine and cross-over mitoxantrone or idarubicin for refractory and relapsed acute myeloid leukemia.
    Bassan R; Lerede T; Buelli M; Borleri G; Bellavita P; Rambaldi A; Barbui T
    Haematologica; 1998 May; 83(5):422-7. PubMed ID: 9658726
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of peripheral blood stem cells for autologous transplantation in acute myeloid leukemia patients allows faster engraftment and equivalent disease-free survival compared with bone marrow cells.
    Visani G; Lemoli R; Tosi P; Martinelli G; Testoni N; Ricci P; Motta M; Gherlinzoni F; Leopardi G; Pastano R; Rizzi S; Piccaluga P; Isidori A; Tura S
    Bone Marrow Transplant; 1999 Sep; 24(5):467-72. PubMed ID: 10482929
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Secondary acute leukemia following mitoxantrone-based high-dose chemotherapy for primary breast cancer patients.
    Kröger N; Damon L; Zander AR; Wandt H; Derigs G; Ferrante P; Demirer T; Rosti G; ; ;
    Bone Marrow Transplant; 2003 Dec; 32(12):1153-7. PubMed ID: 14647269
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Central nervous system relapse in acute promyelocytic leukemia.
    Colovic N; Bogdanovic A; Miljic P; Jankovic G; Colovic M
    Am J Hematol; 2002 Sep; 71(1):60-1. PubMed ID: 12221680
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.